Hubei Xingfa Chemicals Group Co., Ltd. (SHA:600141)
China flag China · Delayed Price · Currency is CNY
37.60
+0.35 (0.94%)
At close: Feb 6, 2026

SHA:600141 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
29,68327,95327,74129,59323,33217,982
Other Revenue
443.9443.9540.3717.79570.02335.02
30,12728,39628,28130,31123,90218,317
Revenue Growth (YoY)
6.49%0.41%-6.69%26.81%30.49%1.54%
Cost of Revenue
24,77323,07223,90219,68515,91915,898
Gross Profit
5,3545,3254,38010,6267,9832,419
Selling, General & Admin
997.541,008832.85823.21641.17497.4
Research & Development
1,2471,1831,1171,232862.18374.06
Other Operating Expenses
442.84481.5322.47256.33205.07151.79
Operating Expenses
2,5992,6862,2692,3141,6991,035
Operating Income
2,7562,6392,1108,3126,2841,384
Interest Expense
-423.04-395.18-327.54-364.36-520.05-554.24
Interest & Investment Income
210.28144.11161.66316.46310.69108.68
Currency Exchange Gain (Loss)
68.0868.0836.1380.44-6.14-14.59
Other Non Operating Income (Expenses)
-29.24-71.19-124.72-125.52-119.83-47.39
EBT Excluding Unusual Items
2,5822,3851,8568,2195,948876.36
Impairment of Goodwill
-233.89-233.89-120.3-24.59-2.52-136.94
Gain (Loss) on Sale of Investments
12.47-22.658.73-100.880.410.95
Gain (Loss) on Sale of Assets
-61.8-63.04-91.03-297.25-466.05-87.57
Asset Writedown
5.63-0.45-27.23-22.88-127.43-10.35
Other Unusual Items
18.9718.97119.2897.6270.7160.24
Pretax Income
2,3232,0831,7457,8715,423702.69
Income Tax Expense
565.08464.7336.671,074689.58105.28
Earnings From Continuing Operations
1,7581,6191,4096,7964,734597.42
Minority Interest in Earnings
-152.6-17.39-7.96-944.61-452.1223.81
Net Income
1,6051,6011,4015,8524,282621.23
Net Income to Common
1,6051,6011,4015,8524,282621.23
Net Income Growth
-8.86%14.33%-76.06%36.67%589.24%105.39%
Shares Outstanding (Basic)
1,1071,1041,1211,1021,1041,018
Shares Outstanding (Diluted)
1,1161,1441,1971,1231,1121,035
Shares Change (YoY)
-9.59%-4.45%6.59%0.99%7.41%12.97%
EPS (Basic)
1.451.451.255.313.880.61
EPS (Diluted)
1.441.401.175.213.850.60
EPS Growth
0.80%19.66%-77.54%35.33%541.67%81.82%
Free Cash Flow
-558.8585.24-1,0964,5203,8271,480
Free Cash Flow Per Share
-0.500.07-0.924.023.441.43
Dividend Per Share
1.0001.0000.6001.0000.5000.250
Dividend Growth
66.67%66.67%-40.00%100.00%100.00%150.00%
Gross Margin
17.77%18.75%15.49%35.06%33.40%13.21%
Operating Margin
9.15%9.29%7.46%27.42%26.29%7.56%
Profit Margin
5.33%5.64%4.95%19.31%17.91%3.39%
Free Cash Flow Margin
-1.85%0.30%-3.88%14.91%16.01%8.08%
EBITDA
5,2344,9274,1459,9747,5472,459
EBITDA Margin
17.38%17.35%14.66%32.91%31.57%13.42%
D&A For EBITDA
2,4792,2882,0341,6621,2631,075
EBIT
2,7562,6392,1108,3126,2841,384
EBIT Margin
9.15%9.29%7.46%27.42%26.29%7.56%
Effective Tax Rate
24.32%22.30%19.29%13.65%12.72%14.98%
Revenue as Reported
30,12728,39628,28130,31123,90218,317
Source: S&P Global Market Intelligence. Standard template. Financial Sources.